Current Situation Data

HCV & its complications are a real burden to healthcare systems. They impact patient's health, social & economic aspects as well. Following are more detailed estimations about HCV burden in Saudi Arabia


Undiagnosed Saudi individuals with active HCV1,2


Estimated new infections
per year1,2


of Saudis living with HCV may be unaware of their infection status.1

[18 Billion]

Estimated Saudi Riyals health costs of HCV in KSA until 2030

Individual Burden

74% of HCV patients

develop extrahepatic manifestation during their illness.4,5

HCV infection can also have an

impact on a patient’s quality of life.6

For Every 100 People Infected with HCV7


Will develop Chronic Infection


Will develop Chronic Liver Disease


Will develop Cirrhosis


Will die of cirrhosis or liver cancer

What we aim to achieve by 2030?

Explore All Data


1. Aljumah AA, Abaalkhail F, et al. Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift. Saudi J Gastroenterol 2016;22:269‑81 2. Altraif I. Can hepatitis C virus be eliminated by 2030? Saudi Arabia as an example. Saudi Medical Journal. 2018;39(8):842-845. 3. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. 4. Douglass CH, et al. BMC Med. 2018;16:175. doi:10.1186/ s12916-018-1162-z 5. Reau N, et al. Hepatol Commun. 2017;1:439–452. doi:10.1002/hep4.1049 6. Vietri J, et al. BMC Gastroenterol. 2013;13:16. doi:10.1186/1471-230X-13-16 7. Ghany MG, Strader DB, ThoHowlader N, et al. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.mas DL, et al. Hepatology. 2009;49(4):1335–1374. EMCDDA Insights. Hepatitis C among drug users in Europe. 2016;

Approval Code: ABBV-SA-00012-MC

Copyright © 2021 AbbVie Inc. North Chicago, Illinois, U.S.A.